Literature DB >> 26456956

Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.

Jianping Zhou1, Weiling Li2, Jianfeng Guo3, Gang Li3, Fang Chen4, Jiangang Zhou5.   

Abstract

Increasing evidence indicates that abnormal microRNA (miRNA) expression is related to hepatocellular carcinoma (HCC) development. Our study aimed to elucidate the essential role of miR-329 in HCC progression. Real-time PCR was used to analyze miR-329 and bromodomain containing 4 (BRD4) expression in HCC samples (n = 135). Cell Counting Kit-8 (CCK-8) and flow cytometric analysis were used to investigate cell proliferation and apoptosis. The transwell assay was used to examine the cell invasive ability. The regulation mechanism was confirmed by luciferase reporter and western blot assays. Kaplan-Meier analysis was used to detect the function of miR-329 on the prognosis of HCC patients. miR-329 was decreased in HCC samples and was related to tumor development. Furthermore, miR-329 significantly regulated cell invasion by targeting BRD4 but had no effect on cell proliferation and apoptosis. Moreover, downregulation of miR-329 predicted poor prognosis of HCC patients. miR-329 could control cell invasion via regulating BRD4 expression and may be a prognostic marker in HCC.

Entities:  

Keywords:  BRD4; HCC; Invasion; Prognosis; miR-329

Mesh:

Substances:

Year:  2015        PMID: 26456956     DOI: 10.1007/s13277-015-4109-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  MicroRNA-127 post-transcriptionally downregulates Sept7 and suppresses cell growth in hepatocellular carcinoma cells.

Authors:  Jiansheng Zhou; Shan Lu; Shengsheng Yang; Huan Chen; Hanping Shi; Mingyong Miao; Binghua Jiao
Journal:  Cell Physiol Biochem       Date:  2014-05-14

2.  BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Pengfei Zhang; Zhaoru Dong; Jiabin Cai; Chi Zhang; Zaozhuo Shen; Aiwu Ke; Dongmei Gao; Jia Fan; Guoming Shi
Journal:  Int J Immunopathol Pharmacol       Date:  2015-03       Impact factor: 3.219

3.  miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.

Authors:  Haifeng Yang; Qi Li; Wohua Zhao; Dun Yuan; Hongyang Zhao; Yong Zhou
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

4.  Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.

Authors:  Salvatore Del Prete; Liliana Montella; Michele Caraglia; Luigi Maiorino; Gregorio Cennamo; Vincenzo Montesarchio; Guido Piai; Antonio Febbraro; Luciano Tarantino; Elena Capasso; Giovannella Palmieri; Rosario Guarrasi; Maddalena Bianco; Rosanna Mamone; Clementina Savastano; Agata Pisano; Bruno Vincenzi; Antonietta Sabia; Alberto D'Agostino; Vincenzo Faiola; Raffaele Addeo
Journal:  Cancer Chemother Pharmacol       Date:  2009-12-30       Impact factor: 3.333

Review 5.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

6.  BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy.

Authors:  M Colombino; P Sperlongano; F Izzo; F Tatangelo; G Botti; A Lombardi; M Accardo; L Tarantino; I Sordelli; M Agresti; A Abbruzzese; M Caraglia; G Palmieri
Journal:  Cell Death Dis       Date:  2012-01-19       Impact factor: 8.469

7.  BRD4 inhibitor inhibits colorectal cancer growth and metastasis.

Authors:  Yuan Hu; Jieqiong Zhou; Fei Ye; Huabao Xiong; Liang Peng; Zihan Zheng; Feihong Xu; Miao Cui; Chengguo Wei; Xinying Wang; Zhongqiu Wang; Hongfa Zhu; Peng Lee; Mingming Zhou; Bo Jiang; David Y Zhang
Journal:  Int J Mol Sci       Date:  2015-01-16       Impact factor: 5.923

8.  MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells.

Authors:  Bingxiang Xiao; Li Tan; Benfu He; Zhiliang Liu; Ruxiang Xu
Journal:  J Transl Med       Date:  2013-07-17       Impact factor: 5.531

9.  MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer.

Authors:  N Akanuma; I Hoshino; Y Akutsu; K Murakami; Y Isozaki; T Maruyama; G Yusup; W Qin; T Toyozumi; M Takahashi; H Suito; X Hu; N Sekino; H Matsubara
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

10.  TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c.

Authors:  J Kim; L Wu; J C Zhao; H-J Jin; J Yu
Journal:  Oncogene       Date:  2013-11-04       Impact factor: 9.867

View more
  8 in total

1.  Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.

Authors:  Haruhiro Yamashita; Sailesh Surapureddi; Ramesh C Kovi; Sachin Bhusari; Thai Vu Ton; Jian-Liang Li; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Cynthia V Rider; Mark J Hoenerhoff; Robert C Sills; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2020-04-18       Impact factor: 5.153

Review 2.  Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.

Authors:  Abdelhakim Bouyahya; Naoufal El Hachlafi; Tarik Aanniz; Ilhame Bourais; Hamza Mechchate; Taoufiq Benali; Mohammad Ali Shariati; Pavel Burkov; José M Lorenzo; Polrat Wilairatana; Mohammad S Mubarak; Nasreddine El Omari
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

3.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.

Authors:  Yue Zhang; Chao Wei; Cong-Cong Guo; Rong-Xiu Bi; Jin Xie; Dong-Hui Guan; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-09-14

4.  Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer.

Authors:  Pihong Li; Jianda Dong; Xiang Zhou; Weijian Sun; He Huang; Tong Chen; Bing Ye; Zhiqiang Zheng; Mingdong Lu
Journal:  Onco Targets Ther       Date:  2017-11-28       Impact factor: 4.147

Review 5.  Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.

Authors:  Erbao Chen; Xiaojing Xu; Ruiqi Liu; Tianshu Liu
Journal:  Biomed Res Int       Date:  2018-05-22       Impact factor: 3.411

6.  Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.

Authors:  Naiyan Wen; Baofeng Guo; Hongwu Zheng; Libo Xu; Hang Liang; Qian Wang; Ding Wang; Xuyang Chen; Shengnan Zhang; Yang Li; Ling Zhang
Journal:  Int J Oncol       Date:  2019-08-29       Impact factor: 5.650

Review 7.  Toward Development of the Male Pill: A Decade of Potential Non-hormonal Contraceptive Targets.

Authors:  Katarzyna Kent; Madelaine Johnston; Natasha Strump; Thomas X Garcia
Journal:  Front Cell Dev Biol       Date:  2020-02-26

8.  A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.

Authors:  Paulina Galka-Marciniak; Martyna Olga Urbanek-Trzeciak; Paulina Maria Nawrocka; Piotr Kozlowski
Journal:  Nucleic Acids Res       Date:  2021-01-25       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.